{
  "id": "Multiple_Myeloma_Response_Criteria.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2021-03-10",
      "name": "Emma Malm",
      "organisation": "Cambio CDS",
      "email": "emma.snygg@hotmail.com"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To measure the multiple myeloma response criteria.",
        "keywords": [
          "multiple",
          "myeloma",
          "criteria"
        ],
        "use": "Use to predict the disease response in multiple myeloma. Diagnosis is based on which criteria are met. Each criterion has a corresponding response category: Complete response (CR), Stringent complete response (sCR), Very good partial response (VGPR), Partial response (PR) and Progressive disease (PD). If no criterion is met, the diagnosis is Stable disease.",
        "copyright": "Cambio CDS"
      }
    },
    "other_details": {
      "references": "1.Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification, and response assessment of multiple myeloma. Leukemia. 2009 Jan;23(1):3-9. doi: 10.1038/leu.2008.291. Epub 2008 Oct 30. Erratum in: Leukemia. 2014 Apr;28(4):980. PMID: 18971951; PMCID: PMC2627786."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.multiple_myeloma_response_criteria.v0",
        "template_id": "openEHR-EHR-OBSERVATION.multiple_myeloma_response_criteria.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]/items[at0017]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]/items[at0020]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]/items[at0023]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]/items[at0026]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]/items[at0029]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]/items[at0032]"
          }
        }
      },
      "gt0013": {
        "id": "gt0013",
        "model_id": "openEHR-EHR-OBSERVATION.multiple_myeloma_response_criteria.v0",
        "template_id": "openEHR-EHR-OBSERVATION.multiple_myeloma_response_criteria.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0018": {
            "id": "gt0018",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0036]"
          }
        }
      }
    },
    "default_actions": [
      "$gt0018|Response category|=local::at0043|Stable disease (SD)|"
    ],
    "rules": {
      "gt0016": {
        "id": "gt0016",
        "priority": 6,
        "when": [
          "$gt0007|Serum M component|!=null",
          "$gt0008|Urine M component|!=null",
          "$gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels|!=null",
          "$gt0010|Bone marrow plasma cell percentage|!=null",
          "$gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas|!=null",
          "$gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder|!=null"
        ],
        "then": [
          "$gt0023|Criteria score|=$gt0007.value+$gt0008.value+$gt0009.value+$gt0010.value+$gt0011.value+$gt0012.value"
        ]
      },
      "gt0017": {
        "id": "gt0017",
        "priority": 5,
        "when": [
          "$gt0023|Criteria score|>=1"
        ],
        "then": [
          "$gt0018|Response category|=local::at0044|Progressive disease (PD)|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 4,
        "when": [
          "$gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required|==local::at0005|Yes|"
        ],
        "then": [
          "$gt0018|Response category|=local::at0042|Partial response (PR)|"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 3,
        "when": [
          "$gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs|==local::at0005|Yes|"
        ],
        "then": [
          "$gt0018|Response category|=local::at0041|Very good partial response (VGPR)|"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 2,
        "when": [
          "($gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence|==local::at0005|Yes|)||(($gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow|==local::at0005|Yes|)&&($gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence|==local::at0005|Yes|))"
        ],
        "then": [
          "$gt0018|Response category|=local::at0040|Stringent complete response (sCR)|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 1,
        "when": [
          "$gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow|==local::at0005|Yes|",
          "!fired($gt0021)"
        ],
        "then": [
          "$gt0018|Response category|=local::at0039|Complete response (CR)|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Multiple Myeloma Response Criteria",
            "description": "Multiple Myeloma Response Criteria predicts disease response in multiple myeloma, from the International Myeloma Working Group (IMWG)."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow",
            "description": ""
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence",
            "description": ""
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs",
            "description": ""
          },
          "gt0006": {
            "id": "gt0006",
            "text": "≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required",
            "description": ""
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Serum M component",
            "description": "Absolute increase must be ≥0.5 g/100 mL"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Urine M component",
            "description": "Absolute increase must be ≥200 mg per 24 hrs"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels",
            "description": "Absolute increase must be >100 mg/L"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Bone marrow plasma cell percentage",
            "description": "Absolute % must be ≥10%"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas",
            "description": ""
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder",
            "description": "Corrected serum calcium must be >11.5 mg/dL"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Calculate total score"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Set Progressive disease"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Response category",
            "description": ""
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Set Partial response"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Set Very good partial response"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Stringent complete response"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Set Complete response"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Criteria score",
            "description": ""
          }
        }
      }
    }
  }
}